While variation in the 3q13.11 region is associated with expression levels of ALCAM, BBX, CBLB, CD47 IFT57, and MYH15 in the brain, only ALCAM and BBX were significantly differentially expressed between AD cases and controls. This evidence concerns the gene ALCAM and Alzheimer disease.